Role of PSMA Imaging in Selecting Patients for Biopsies (Urologic Perspective)
Dr. Lorenzo Bianchi reviews how PSMA PET may refine biopsy selection, complement MRI, and reduce unnecessary systematic biopsies in prostate cancer.
Read More
Select Page
Lorenzo Bianchi, MD, PhD, FEBU, is Medical Director of Urology and an Associate Professor in the Department of Medical and Surgical Sciences at the University of Bologna in Bologna, Italy. Dr. Bianchi specializes in prostatic hypertrophy, urinary lithiasis, and cancers of the prostate, bladder, kidneys, and testis.
Dr. Bianchi earned his medical degree and a Master’s degree in Surgery from the University of Bologna. He then completed training in Sectoral Anatomy at Cardiff University in Cardiff, United Kingdom. Dr. Bianchi also studied Sectoral Anatomy at the Roswell Park Comprehensive Cancer Center in Buffalo, New York. Dr. Bianchi then completed Advanced Robotic Surgery at the Careggi Hospital in Florence, Italy. He also completed a clinical fellowship in Robotic Urological Surgery at OLV Hospital in Lackawanna, New York. Dr. Bianchi then completed a fellowship in Radio-Guided Surgery with an emphasis in prostate cancer at Marini Klinik in Hamburg, Germany. He also obtained his PhD in Nephro-Cardio-Thoracic Sciences at the University of Bologna with a three-year research project entitled "3D modelling and 3D printing for preoperative planning in minimally invasive kidney surgery".
Dr. Bianchi conducts research on robotic surgery techniques in prostate, renal and bladder cancer; surgery guided by 3D models, augmented reality, and artificial intelligence; minimally invasive surgery of prostate cancer (high-intensity focused ultrasound) and renal cancer (cryoablation and radiofrequency ablation); benign prostatic hypertrophy; and advanced diagnosis of prostate cancer. Dr. Bianchi has authored and co-authored over 400 publications and has participated in numerous conferences internationally. He is a Fellow of the European Board of Urology.
Lorenzo Bianchi, MD, PhD, FEBU | Mar 2026
Dr. Lorenzo Bianchi reviews how PSMA PET may refine biopsy selection, complement MRI, and reduce unnecessary systematic biopsies in prostate cancer.
Read More